GL1X · GenesisL1 explorer

MolNFT v1 · #104704 · protein

Structure of the human smoothened receptor in complex with anta xv

4QIM · Smoothened HOMOLOG/SOLUBLE cytochrome B562 chimeric protein: “Structure of the human smoothened receptor in complex with anta xv”. X-ray diffraction, 2 ligands (A8T, ZN), 3 pockets (best druggability 0.85). MolNFT v1 #104704 on…

PDB
4QIM
Type
protein
Length
457 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Smoothened HOMOLOG/SOLUBLE cytochrome B562 chimeric protein
UniProt
Q99835, P0ABE7
Ligands
A8T, ZN
Pockets
3 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 71% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASmoothened HOMOLOG/SOLUBLE cytochrome B562 chimeric proteinprotein45771% helix, 5% strandQ99835, P0ABE7

Ligands and binding sites

  • A8T · 2-{6-[4-(4-benzylphthalazin-1-yl)piperazin-1-yl]pyridin-3-yl}propan-2-ol · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12490.850.9635A8T
2990.390.7616empty
3820.340.7520empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4QIM · Structure of the human smoothened receptor in complex with ANTA XV · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99835 · AlphaFold monomer V2.0 prediction for smoothened homolog (Q99835) · a predicted model of the same protein · chain A against A, TM-score 0.75
  • P0ABE7 · AlphaFold monomer V2.0 prediction for soluble cytochrome B562 (P0ABE7) · a predicted model of the same protein · chain A against A, TM-score 0.24

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.